Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis

Download
  1. Get@NRC: Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis (Opens in a new window)
AuthorSearch for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleVaccine
Volume25
Issue19
Pages37813791; # of pages: 11
Subjectadministration & dosage; Administration,Oral; Animals; Antibodies; Antibodies,Bacterial; antibody; Bacteria; bacterial; Bacterial Vaccines; Blood; Canada; Female; FLUID; Form; FORMS; Francisella tularensis; Humans; Immunization; immunology; INFECTION; Inflammation; Liver; Lung; Lymphocyte Activation; Methods; Mice; Mice,Inbred BALB C; Mice,Inbred C57BL; Microbiology; MODEL; mortality; pathogenicity; POTENTIAL; prevention & control; PROTECTION; Serum; Spleen; STRAIN; STRAINS; Tularemia; Vaccines; Vaccines,Attenuated; Virulence
AbstractFrancisella tularensis is a Gram-negative intracellular bacterium, and the causative agent of tularemia. The infection can be initiated by various routes and can manifest itself in several clinical forms with the disseminated typhoidal form initiated by inhalation being most fatal. The attenuated live vaccine strain (LVS), developed almost 50 years ago, remains the sole effective tularemia vaccine, which is still only available as an investigational new drug for at-risk individuals. This vaccine, when given by scarification, appears to provide solid protection against subsequent systemic infection with clinical strains of F. tularensis, but its efficacy against respiratory infection is less satisfactory. In this study, we evaluated the potential of oral immunization with LVS for eliciting protection against systemic and respiratory infection with virulent F. tularensis strains in a mouse model of tularemia. Oral LVS immunization was highly effective at protecting Balb/c mice against lethal systemic or respiratory challenges with type A and type B F. tularensis. Compared to sham-immunized mice, oral LVS-immunized mice showed significant reductions in burdens of virulent F. tularensis in the lung and spleen and milder tissue damage and inflammation in the liver. The immunization induced F. tularensis-specific antibody responses in the serum and bronchoalveolar lavage fluids, as well as antigen-specific splenocyte proliferation and IFN-gamma and IL-2 production. The protective efficacy was related to the size of the immunizing dose but not the number of doses administered. Like other routes of LVS immunization in mice, the protective immunity induced by oral immunization was relatively short-lived. These results suggest that oral immunization should be explored further as an alternative vaccination strategy to combat tularemia
Publication date
LanguageEnglish
AffiliationNRC Institute for Biological Sciences; National Research Council Canada
Peer reviewedNo
NRC numberKUOLEE2007A
NPARC number9359056
Export citationExport as RIS
Report a correctionReport a correction
Record identifierc1c03247-8028-4c95-a48f-c22c77424989
Record created2009-07-10
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)